��������

The Leadership Team at Oryzon Genomics is responsible for guiding the strategic direction of the company, overseeing the development of innovative epigenetic therapies, and ensuring operational excellence. This diverse group of executives collaborates to enhance clinical programs, drive business growth, and promote scientific advancements while aligning with regulatory standards and intellectual property strategies. Their collective expertise fosters a culture of innovation and accountability, positioning Oryzon Genomics for success in the biopharmaceutical industry.